WALTHAM, Mass.--(BUSINESS WIRE)--Today, PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced the availability on the App Store of the ChemDraw® and Chem3D® apps. With over a million users around the world, ChemDraw is the recognized standard drawing tool not only for chemists in education and R&D, but also for those publishing structures in scientific articles, journals and patents. The new mobile ChemDraw and Chem3D apps also feature PerkinElmer’s Flick-to-ShareTM technology, a groundbreaking development in scientific collaboration and data sharing that brings molecular education to a new level, allowing scientists to share critical information and spark innovation in real-time both in and out of the laboratory.
Since 1986 when it first became available on the Macintosh, the ChemDraw software suite has been considered the gold-standard among scientists world-wide, allowing them to draw, study and save molecules and chemical reactions. Three decades later, with the new app for iPad®, the global chemical drawing community will now have the freedom to draw and share chemical structures everywhere and every time inspiration strikes.
"The launch of ChemDraw and Chem3D technology in a mobile form is a major milestone in the field of scientific computing,” said Michael Stapleton, Vice President and General Manager, Informatics at PerkinElmer. “As the global leader in chemical drawing, we can now provide all chemists - from research scientists to high school students - with cost effective, portable and accessible applications that capture and share their moments of inspiration. Now everyone, from relative newcomers to the most experienced chemists, can quickly sketch and save ideas and then easily share them, bringing the power of PerkinElmer’s ChemDraw and Chem3D technology to the fingertips of researchers.”
The Chem3D app is a 3D molecular viewer that allows users to download 3D structures of many types and display them with unique versatility. Scientists can explore the 3D structures by using simple touch gestures to rotate, expand and contract the models for a richer view of their spatial properties. The flexibility of the Chem3D app’s display helps researchers and students gain a better understanding of the 3D nature of molecules and how their shapes influence their properties. The Chem3D app can display 3D models as ball-and-stick, wireframe, space-filling and cartoon and can apply these modes to a wide variety of structures including proteins, DNA, RNA, crystals, assemblies and small organics.
Flick-to-Share™ Technology
The ChemDraw and Chem3D apps feature Flick-to-Share technology, a patent-pending sharing tool developed by PerkinElmer, along with support for multiple file formats and import/export capabilities. The Flick-to-Share technology gives users the ability to easily and rapidly share molecular structures across mobile devices, requiring only a single finger swipe gesture to transfer images from one to another user regardless of geographic location. The Flick-to-Share technology allows users to eliminate the need for multi-step emails or cloud storage services.
Robin Smith, Vice President R&D of Informatics at PerkinElmer added, “These mobile apps have been developed by the same team that developed the ChemDraw and Chem3D software technology for the PC and Apple’s Mac® computer. Scientists can be confident that the mobile apps will embody the same depth of chemistry knowledge, attention to detail and passion for science that is part of the ChemDraw technology tradition."
The ChemDraw and Chem3D apps are the first of a series of mobile applications PerkinElmer is developing to innovate on its leading electronic laboratory notebook (ELN) and scientific instrument franchises. PerkinElmer’s ImageENTRY™ application for the iPhone®, for example, will simplify and secure the process for scientists inputting images and data into their PerkinElmer E-Notebook. PerkinElmer leverages its deep scientific knowledge and expertise in the development of the most comprehensive suite of scientific informatics and software solutions - from instrument generated data, to enterprise solutions to mobile applications. Built by scientists for scientists, PerkinElmer’s integrated business-wide information management system provides companies and academic institutions with the necessary tools to aggregate, search, mine, analyze and visualize critical data so that they can turn data into actionable insights in an automated, predictive and scalable way.
ChemDraw is available for the introductory price of $9.99 (US dollars) and Chem3D is available free of charge from the App Store or at www.itunes.com/appstore.
Factors Affecting Future Performance
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities and divestitures. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products declining or not growing as anticipated; (2) fluctuations in the global economic and political environments; (3) our failure to introduce new products in a timely manner; (4) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable, or successfully divest businesses; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply of raw materials and supplies; (11) the manufacture and sale of products exposing us to product liability claims; (12) our failure to maintain compliance with applicable government regulations; (13) regulatory changes; (14) our failure to comply with healthcare industry regulations; (15) economic, political and other risks associated with foreign operations; (16) our ability to retain key personnel; (17) significant disruption in our information technology systems; (18) our ability to obtain future financing; (19) restrictions in our credit agreements; (20) our ability to realize the full value of our intangible assets; (21) significant fluctuations in our stock price; (22) reduction or elimination of dividends on our common stock; and (23) other factors which we describe under the caption "Risk Factors" in our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
About PerkinElmer
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $2.1 billion in 2012, has about 7,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com. Join in the conversation at www.twitter.com/perkinelmernews.
